Clinical trial NCT00771069: Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and Hypertension
Official title: A Retrospective, Multi Centre, Non-interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Type II Diabetes Mellitus Patients With DM Related Complication and Hypertension.
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Hypertension
Keywords: Hypertension
Type II DM
DM related complication
JNC7
2007 ESH-ESC guidelines
survey
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2008-10-10
Enrollment: 2000
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Type II Diabetes Mellitus patients with Complication and Hypertension

Brief summary: This study will address the treatment rate and control rate of hypertension, treatment pattern and factors to affect blood pressure control by examining (retrospective) medical records of Type II DM patients with DM related complication and hypertension, among outpatients coming to the Endocrinology Department in 20 general hospital settings nationwide.


Eligibility criteria: Inclusion Criteria:

* After diagnosed type II DM, patients received treatment for a least 3 years
* Type II DM patients with hypertension and its complication.
* Visited out-patients to care center after 1 Jan. 2008

Exclusion Criteria:

* Secondary hypertension patients
* Patients not receiving hypertension medication
* Patients stopping BP medication, by physician's order
* Patients currently enrolled in other clinical studies

Primary outcomes:
measure: Attainment rate to the target blood pressure.
timeFrame: After collecting all Patient Record Form.
Secondary outcomes:
measure: Attainment to the target blood pressure will be investigated according to DM related complications.
timeFrame: After collecting all Patient Record Form.
measure: Change in the DBP/SBP value will be investigated according to the DM Complication
timeFrame: After collecting all Patient Record Form.
measure: Treatment pattern and factors that affect BP control
timeFrame: After collecting all Patient Record Form.
Other outcomes:
Locations:
city: Bucheon
country: Korea, Republic of
facility: Research Site
state: Gyeonggi
city: Goyang
country: Korea, Republic of
facility: Research Site
state: Gyeonggi
city: Guri
country: Korea, Republic of
facility: Research Site
state: Gyeonggi
city: Sungnam
country: Korea, Republic of
facility: Research Site
state: Gyeonggi
city: Suwon
country: Korea, Republic of
facility: Research Site
state: Gyeonggi
city: Wonju
country: Korea, Republic of
facility: Research Site
state: Kangwon
city: Jeonju
country: Korea, Republic of
facility: Research Site
state: Keollabuk
city: Busan
country: Korea, Republic of
facility: Research Site
city: Deagu
country: Korea, Republic of
facility: Research Site
city: Deajeon
country: Korea, Republic of
facility: Research Site
city: Incheon
country: Korea, Republic of
facility: Research Site
city: Kwangju
country: Korea, Republic of
facility: Research Site
city: Seoul
country: Korea, Republic of
facility: Research Site
Study officials:
affiliation: Astrazenca Korea
name: Joonwoo Bahn
role: STUDY_DIRECTOR
References: